Paradigm Biopharmaceuticals Ltd
ASX:PAR
Paradigm Biopharmaceuticals Ltd
ASX:PAR
Price:
0.17
AUD
3.03%
Market Closed
Market Cap:
AU$76.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Paradigm Biopharmaceuticals Ltd
ASX:PAR
|
AU |
|
I
|
IMPACT Growth Real Estate Investment Trust
SET:IMPACT
|
TH |
|
Fletcher Building Ltd
F:FLQ
|
NZ |
|
Lynas Rare Earths Ltd
ASX:LYC
|
MY |
|
Cal-Maine Foods Inc
NASDAQ:CALM
|
US |
|
Brunello Cucinelli SpA
OTC:BCUCF
|
IT |
|
Cooper-Standard Holdings Inc
NYSE:CPS
|
US |
|
C
|
CME Group Inc
DUS:MX4A
|
US |
|
H
|
Hisense Home Appliances Group Co Ltd
HKEX:921
|
CN |
|
Microsoft Corp
NASDAQ:MSFT
|
US |
|
A
|
American Campus Communities Inc
F:FGA
|
US |
Wall St Price Targets
PAR Price Targets Summary
Paradigm Biopharmaceuticals Ltd
Paradigm Biopharmaceuticals Ltd
Wall Street analysts forecast PAR stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for PAR is 0.66 AUD with a low forecast of 0.66 AUD and a high forecast of 0.68 AUD.
Lowest Forecast
Price Target
0.66
AUD
286% Upside
Average Forecast
Price Target
0.66
AUD
290% Upside
Highest Forecast
Price Target
0.68
AUD
301% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PAR's stock price target?
Price Target
0.66
AUD
0.66
AUD
According to Wall Street analysts, the average 1-year price target for PAR is 0.66 AUD with a low forecast of 0.66 AUD and a high forecast of 0.68 AUD.
What is the Revenue forecast for Paradigm Biopharmaceuticals Ltd?
Projected CAGR
185%
185%
Over the last 10 years, the compound annual growth rate for Revenue has been 99%. The projected CAGR for the next 3 years is 185%.
